Wall Street Zen lowered shares of Neuphoria Therapeutics (NASDAQ:NEUP – Free Report) from a hold rating to a sell rating in a report released on Sunday morning. NEUP has been the topic of a number of other research reports. HC Wainwright restated a “buy” rating and set a $21.00 target price on shares of Neuphoria […]

Wall Street Zen lowered shares of Eupraxia Pharmaceuticals (NASDAQ:EPRX – Free Report) from a hold rating to a sell rating in a research note published on Sunday morning. Several other equities analysts also recently issued reports on the stock. HC Wainwright restated a “buy” rating and set a $12.00 price objective on shares of Eupraxia […]

Luminar Technologies (NASDAQ:LAZR – Get Free Report) was upgraded by equities research analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research note issued on Monday. Other analysts have also recently issued reports about the company. JPMorgan Chase & Co. restated an “underweight” rating on shares of Luminar Technologies […]